Veradermics (MANE) Other Gross PP&E Adjustments (2024 - 2026)
Veradermics posted quarterly Other Gross PP&E Adjustments of -$3.3 million for Q1 2026, up 25.92% on a QoQ basis from -$4.4 million in Q4 2025.
Veradermics (MANE) has 3 years of Other Gross PP&E Adjustments data on file, last reported at -$3.3 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments changed N/A year-over-year to -$3.3 million; the trailing twelve-month figure through Mar 2026 stood at -$3.3 million (changed N/A YoY), and the FY2025 full-year result was -$4.4 million, down 1097.04% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$3.3 million, up from -$4.4 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$371000.0 in Q4 2024 and bottomed at -$4.4 million in Q4 2025.
- The 3-year median for Other Gross PP&E Adjustments is -$3.3 million (2026), against an average of -$2.7 million.
- Peak annual rise in Other Gross PP&E Adjustments reached 1097.04% in 2025, while the deepest fall reached 1097.04% in 2025.
- A 3-year view of Other Gross PP&E Adjustments shows it stood at -$371000.0 in 2024, then tumbled by 1097.04% to -$4.4 million in 2025, then gained by 25.92% to -$3.3 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$3.3 million (Q1 2026), -$4.4 million (Q4 2025), and -$371000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Veradermics | 2.29 Bn | 2.29 Bn | - | -3.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.29 Mn |
| Mar 31, 2026 | -3.29 Mn |
| Dec 31, 2025 | -4.44 Mn |
| Dec 31, 2025 | -4.44 Mn |
| Dec 31, 2024 | -371,000.00 |
| Dec 31, 2024 | -371,000.00 |